New Delhi: The Delhi High Court today directedthe Drug Controller General of India to process the licenceapplication of Cipla for production and sale of genericversion of global pharma major Bayer Corporation`s liver andkidney cancer drug `Nexavar`.
Officer dies in mishap on INS Kolkata
Jagdambika Pal resigns from Congress
SC rejects Sahara`s refund proposal
Doctors` strike: Has someone from your family died? Mulayam asks mediamen